‘Alarming’ rise in diabetes globally by 2050- study
By Jennifer Rigby LONDON (Reuters) – Every country in the world will see rates of diabetes rise in the next…
Health
US appeals court vacates travel mask mandate ruling
By David Shepardson WASHINGTON (Reuters) – A U.S. appeals court panel Thursday vacated an April 2022 ruling that had declared…
US FDA approves Sarepta’s gene therapy for rare muscular dystrophy in some kids
By Leroy Leo and Aditya Samal (Reuters) – The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics’ first-of-its-kind…
U.S. court strikes down Florida transgender health rule
By Daniel Trotta (Reuters) – A U.S. judge on Wednesday struck down a Florida rule and a statute that banned…
Novo Nordisk says EMA raised safety signal on drugs including semaglutide
By Nikolaj Skydsgaard COPENHAGEN (Reuters) -A thyroid cancer safety signal was raised by the EU’s drugs watchdog last month over…
Orpea creditors Kyma Capital, LMR apply to US court to obtain documentation
LONDON (Reuters) – Two creditors of France’s Orpea have filed an application in a U.S. court against another creditor and…
Pope skips speech, blaming breathing difficulties after surgery
VATICAN CITY (Reuters) – Pope Francis skipped reading a planned speech at a conference on Thursday, saying he still had…
Aegon bets on Transamerica to boost cash flow and dividend in 2025
(Reuters) -Transamerica owner Aegon on Thursday forecast a higher free cash flow and dividend in 2025, flagging untapped potential in…
Australia’s Telix Pharma hits record high after buying UK medical devices firm
(Reuters) – Telix Pharmaceuticals rose over 3% on Thursday to hit an all-time high, after the radiopharma company said it…
US CDC advisers recommend older adults may receive Pfizer, GSK shots for RSV
By Michael Erman and Raghav Mahobe (Reuters) -A panel of advisers to the U.S. Centers for Disease Control and Prevention…